准Alk4通路可以防止与年龄相关的骨质损失
bioRxiv : the preprint server for biology
|November 24, 2025
概括
活性蛋白信号通过抑制骨质母细胞功能,加剧了与年龄相关的骨质损失. 用Alk4-Fc准这种途径可以保存骨质,并可能对抗老年小鼠的肉症.
科学领域:
- 骨生物学与衰老 骨生物学与衰老
- 内分泌学 在内分泌学.
- 老年学是一门学科.
背景情况:
- 骨质疏松症的特征是骨质细胞和骨质细胞活动失衡,导致骨质损失.
- 目前的疗法主要针对骨质细胞,在老化骨中增强骨质细胞功能的选择有限.
- 随着年龄的增长,循环活动素水平的升高表明,与年龄相关的骨病理可能起作用.
研究的目的:
- 为了调查Activin信号在与年龄相关的骨质损失中的作用.
- 为了确定抑制Activin信号传递是否可以在老年小鼠中保持骨质和骨质母细胞功能.
- 探索针对阿克提因治疗骨质疏松症和肉症的潜力.
主要方法:
- 在老老的小鼠大腿骨中评估了Activin信号传递和椎骨.
- 产生骨质细胞特异性Alk4淘汰赛 (cKO) 的小鼠来研究Activin的作用.
- 向老年小鼠注射了一种Activin联体陷 (Alk4-Fc),并评估了骨和肌肉的参数.
主要成果:
- 随着年龄的增长,激素信号增加,与椎骨损失相关.
- Alk4 cKO小鼠表现出增强的骨收购,骨质母细胞数量的增加和保存的骨形成.
- 在老年小鼠中,Alk4-Fc治疗保护了大腿和脊椎的骨质损失,并防止了肌肉质量下降.
结论:
- 循环活动素在抑制骨形成和驱动与年龄相关的骨质损失方面发挥着重要作用.
- 通过Alk4抑制Activin信号传递是一种有前途的骨质疏松症治疗策略.
- 向阿提可以提供双重好处,也解决与年龄相关的肌肉损失 (肉症).
相关概念视频
01:29Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
01:31Osteoclasts in Bone Remodeling
3.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.8K
01:40Bone Remodeling
40.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.2K
01:25Role of Vitamins in Maintaining Bone Health
5.0K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
5.0K
01:19The Effect of Aging on Tissues
3.1K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.1K
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
186
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
186